[The iron letter--an update on the treatment of iron deficiency anemia].
Iron deficiency is a frequent complication in chronically ill patients and in pregnant women. Iron status can now be characterised precisely and relatively easily by determining serum ferritin, transferritin saturation and if necessary hypochromic erythrocytes and the haemoglobin content of erythrocytes (CHr). Oral iron replacement is usually restricted by limited absorption and low tolerability. Intravenous iron therapy is possible in such cases and can be combined with rHuEPO (e.g. EPREX/Epoetin alfa) in severe cases. Iron saccharate Switzerland and this permits high dose iron replacement without any danger of anaphylaxis or acute iron toxicity.
Schaefer
R M
RM
Universitätsklinikum Münster, Innere Medizin D, Deutschland.
Huch
R
R
Krafft
A
A
D000284:Administration, Oral; D000328:Adult; D000367:Age Factors; D000368:Aged; D018798:Anemia, Iron-Deficiency / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D003430:Cross-Sectional Studies; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000008:administration & dosage*; D005260:Female; D005293:Ferritins / Q000032:analysis; D006452:Hemoglobinometry; D006801:Humans; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D058085:Iron Compounds / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009751:Nutritional Requirements; D011247:Pregnancy; D012307:Risk Factors; D014168:Transferrin / Q000032:analysis
D058085:Iron Compounds; D014168:Transferrin; D004921:Erythropoietin; D005293:Ferritins